SCHEMBL8202721

SCHEMBL8202721

COc1ccccc1-c1cccc2oc(-c3ccccc3C3=NCCN3)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NISCH Q9Y2I1 8/20 0.47
▸ ALDH1A1 P00352 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ ADRA2A P08913 1/20 0.46
▸ ADRA2B P18089 1/20 0.46
▸ ADRA2C P18825 1/20 0.46
▸ MAOA P21397 1/20 0.46
▸ MAOB P27338 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ CYP3A4 P08684 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ GMNN O75496 1/20 0.43
▸ RAF1 P04049 1/20 0.43
▸ TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8188884 0.84 NISCH (0.58) NISCHALDH1A1HPGDCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL8196901 0.84 NISCH (0.50) NISCHALDH1A1HPGDCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL8202804 0.81 NISCH (0.59) NISCHALDH1A1HPGDCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL8201933 0.81 NISCH (0.46) NISCHALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL8189601 0.81 NISCH (0.49) NISCHALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL8188068 0.81 NISCH (0.50) NISCHALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL8194659 0.80 NISCH (0.58) NISCHADRA2AADRA2BADRA2CPDCD1LG2
SCHEMBL8200480 0.80 NISCH (0.44) NISCHALDH1A1HPGDCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL8188988 0.79 NISCH (0.46) NISCHALDH1A1HPGDCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL8197571 0.78 NISCH (0.46) NISCHALDH1A1HPGDCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 — — WO disclosed
Send feedback